IPO market

Unlisted Ideas

Invest in Pre-IPO shares

IPO Ideas

Invest in IPO in just 3 clicks

About Us

Corona Remedies IPO listing date & price

BBMainboardBSE,NSEListed

Listed at

1470

+38.42%

Corona Remedies IPO is a Mainboard book building IPO. Issue size is 655.37 Cr. Price band is ₹1008 to ₹1062 per share. Minimum investment is ₹14,868. Lot size is 14 shares. Open from 8 Dec 2025 to 10 Dec 2025. Allotment on 11 Dec 2025. Listing on 15 Dec 2025 at BSE,NSE. Managed by JM Financial Ltd., IIFL Capital Services Ltd., and Kotak Mahindra Capital Co.Ltd. Registrar: Bigshare Services Pvt Ltd. Key details for GMP, subscription, price, allotment, and listing in one place.

Official documents: RHP and DRHP.

Follow the latest IPO & unlisted research on iOS and Android.

Google Play App Store

Corona Remedies IPO listing date & price

BBMainboardBSE,NSEListed

Listed at

1470

+38.42%

Official documents: RHP and DRHP.

Corona Remedies IPO — listing

Official listing price and performance versus the issue price, after the stock debuts on the exchange.

Listing snapshot

Official listing versus the issue price for this debut.

Listing price

₹1470

Vs issue price

+38.42%

Gain

Issue price

₹1,062

How to read this

Listing performance is the percentage move from the issue price to the first official exchange print. It reflects market pricing at listing, not advice about future returns.

Corona Remedies IPO listing FAQs

How listing price and listing performance work.

What is the Corona Remedies IPO listing price?

The Corona Remedies IPO listing price is the price at which the company's shares are listed on the stock exchange after the IPO allotment process. It may be at a premium or discount to the issue price depending on market demand and sentiment.

When is the Corona Remedies IPO listing date?

The Corona Remedies IPO listing date is the date when the company's shares are listed on the stock exchanges (NSE/BSE) and become available for trading. It is usually announced after the allotment process is completed.

What is the Corona Remedies IPO allotment date?

The Corona Remedies IPO allotment date is when the company finalizes share allocation to applicants. After allotment, you can check your status on the registrar's portal using your application number, PAN, or DP ID.

What is listing gain or loss in Corona Remedies IPO?

Listing gain or loss is the difference between the listing price and the issue price. A positive listing gain means the share listed above the issue price; a loss means it listed below. Past listing performance does not guarantee future results.

Where can I check Corona Remedies IPO allotment status?

You can check Corona Remedies IPO allotment status on the registrar's website or the exchange portal once allotment is finalized. You will need your application number, PAN, or DP ID/Client ID to verify your allotment.

How is the Corona Remedies IPO listing price determined?

The Corona Remedies IPO listing price is determined by market demand and supply on the listing day. Factors include subscription response, company fundamentals, sector sentiment, and overall market conditions.

Can the Corona Remedies IPO listing price differ from the issue price?

Yes, the Corona Remedies IPO listing price can be different from the issue price. It may list at a premium (above issue price) or at a discount (below issue price) depending on market conditions at the time of listing.

How is listing performance calculated for Corona Remedies IPO?

Listing performance for Corona Remedies IPO is calculated as the percentage change from the issue price to the listing price. It is for informational purposes only and does not guarantee similar outcomes for other IPOs.

Follow the latest IPO & unlisted research on iOS and Android.

Google Play App Store

Explore IPO market for more details

Corona Remedies IPO — listing

Official listing price and performance versus the issue price, after the stock debuts on the exchange.

Listing snapshot

Official listing versus the issue price for this debut.

Listing price

₹1470

Vs issue price

+38.42%

Gain

Issue price

₹1,062

How to read this

Listing performance is the percentage move from the issue price to the first official exchange print. It reflects market pricing at listing, not advice about future returns.